Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has reported strengthened client feedback and announced refinements to its leadership and communication ...
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...
Q3 2025 Earnings Call Transcript October 30, 2025 Terex Corporation beats earnings expectations. Reported EPS is $1.5, ...
Flushing Financial Corporation (NASDAQ: FFIC) Q3 2025 Earnings Call Transcript October 30, 2025 ...
Preliminary results confirm earlier findings that inobrodib in combination with pomalidomide + dexamethasone (InoPd) for multiple myeloma has promising clinical activity and a tolerable safety profile ...
Ladies and gentlemen, welcome to The Navigator Company conference call and webcast for the third quarter and 9 months results. Joining us today are the following directors: Antonio Redondo, Fernando ...
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...
RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...
Reinharz Highlights AITX’s Strengthening Financials, AI Innovation, and Long-Term Growth Strategy Detroit, Michigan–(Newsfile ...
Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-exp ...
Connect Biopharma Holdings Limited ( CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases November 3, 2025 4:15 PM EST ...